rs192919234
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PP3_ModeratePP5_Very_Strong
The NM_020461.4(TUBGCP6):c.895C>T(p.Arg299*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_020461.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- microcephaly and chorioretinopathy 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020461.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TUBGCP6 | NM_020461.4 | MANE Select | c.895C>T | p.Arg299* | stop_gained | Exon 2 of 25 | NP_065194.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TUBGCP6 | ENST00000248846.10 | TSL:1 MANE Select | c.895C>T | p.Arg299* | stop_gained | Exon 2 of 25 | ENSP00000248846.5 | ||
| TUBGCP6 | ENST00000439308.7 | TSL:1 | n.895C>T | non_coding_transcript_exon | Exon 2 of 25 | ENSP00000397387.2 | |||
| TUBGCP6 | ENST00000498611.5 | TSL:1 | n.1428C>T | non_coding_transcript_exon | Exon 2 of 23 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152160Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 250758 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461476Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727008 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152278Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Microcephaly and chorioretinopathy 1 Pathogenic:2
The c.895C>T;p.(Arg299*) variant creates a premature translational stop signal in the TUBGCP6 gene. It is expected to result in an absent or disrupted protein product - PVS1. ClinVar contains an entry for this variant (Clinvar ID:212517) - PS4_supporting. The variant is present at low allele frequencies population databases (rs192919234 – gnomAD 0.0002127%; ABraOM 0.000427 frequency - https://abraom.ib.usp.br/) - PM2_supporting. In summary, the currently available evidence indicates that the variant is pathogenic.
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg299*) in the TUBGCP6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TUBGCP6 are known to be pathogenic (PMID: 25344692). This variant is present in population databases (rs192919234, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with TUBGCP6-related conditions. ClinVar contains an entry for this variant (Variation ID: 212517). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Microcephaly and chorioretinopathy with or without intellectual disability Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at